avatar
TearSolutions

    Charlottesville, VA, USA

    Founded January 2013

    3 Employees

    C Corporation

    Medical Devices, Pharmaceuticals, Medical Facilities and Services

Key People

Tom Gadek

CEO

Gordon Laurie

CSO

Mark Logan

Executive Chairman

Description
TearSolutions is a clinical-stage biotechnology company spun out of the University of Virginia that is advancing topical treatments for dry eye. The drug, Lacripep, is a synthetic fragment of the human tear protein Lacritin discovered and developed with National Eye Institute funding. Topical Lacripep is a breakthrough opportunity that in preclinical studies eliminates corneal staining and independently promotes basal tearing without irritation for hours by natural physiological processes.
Updates Feed

    Today

    • Document Lorem

      document.pdf
      1
      Public
    • Announcement Lorem

      Public
    • Note Lorem

      Public

Sign up to see more data and start a conversation.

Already a user? Sign in